<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We present a six-year follow-up of a boy with a novel type of <z:hpo ids='HP_0010981'>hypolipoproteinemia</z:hpo>, with clinical and biochemical features distinct from classical <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemias</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>There were abnormally low concentrations of total and <z:chebi fb="6" ids="39025">high-density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>) cholesterol, <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> (apo) B, apo A-I, and apo A-II, and the <z:chebi fb="1" ids="16247">phospholipids</z:chebi> were decreased </plain></SENT>
<SENT sid="2" pm="."><plain>The most striking abnormality was an extra fraction containing mainly <z:chebi fb="1" ids="16247">phospholipids</z:chebi> and apo A-I in the HDL3 subfraction </plain></SENT>
<SENT sid="3" pm="."><plain>This fraction is reminiscent of concentric 20- to 50-nm-diameter lamellar <z:chebi fb="0" ids="16247">phospholipid</z:chebi> liposomes </plain></SENT>
<SENT sid="4" pm="."><plain>Plasma lecithin:cholesterol acyltransferase activity was strongly decreased </plain></SENT>
<SENT sid="5" pm="."><plain>We noted a persisting polyclonal <z:hpo ids='HP_0010702'>hypergammaglobulinemia</z:hpo>, <z:hpo ids='HP_0001871'>hematological abnormalities</z:hpo> (<z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo> and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>), and a progressive <z:hpo ids='HP_0001744'>splenomegaly</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>After the five-year follow-up, the patient had recurrent severe <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>; moderate <z:hpo ids='HP_0000790'>hematuria</z:hpo> and <z:hpo ids='HP_0000093'>proteinuria</z:hpo> developed gradually </plain></SENT>
<SENT sid="7" pm="."><plain>Treatment with <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> and immunoglobulins improved <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and <z:hpo ids='HP_0010981'>hypolipoproteinemia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>These clinical and biochemical findings differ from those in the known primary and secondary <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypo-alpha-lipoproteinemia</z:e> syndromes </plain></SENT>
<SENT sid="9" pm="."><plain>Although investigation of the relatives suggests a <z:hpo ids='HP_0001472'>familial predisposition</z:hpo> for <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypo-alpha-lipoproteinemia</z:e>, the subject's condition can be regarded as acquired </plain></SENT>
</text></document>